9.5
[1]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 00;7(8):998-985.
[]. Scheepstra M, et al. Bivalent Ligands for Protein Degradation in Drug Discovery. Comput Struct Biotechnol J. 019;17:160-176. Published 019 Jan 5.
H30-H315-H319-H335
P61-P6-P70-P71-P80-P30+P35-P30+P30-P330-P36+P36-P05-P501